Extended release venlafaxine formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8668932
APP PUB NO 20110165234A1
SERIAL NO

13051076

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ANDRX PHARMACEUTICALS LLCFLA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Chin Ming Taipei, TW 15 90
Cheng, Xiu-Xiu Weston, US 14 203
Dixit, Manesh Sunrise, US 7 201
Nangia, Avinash Weston, US 62 1261

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 11, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00